Catalyst Wire Dossier Catalyst Wire Dossier

Treprostinil Palmitil Inhalation Powder

treprostinil palmitil · Insmed Incorporated
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Treprostinil Palmitil Inhalation Powder, covering 2023-09-22 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension [Phase 2]

See pricing